Dr. Anthony P. Blalock, M.D.
Nephrology (Kidney) (Nephrology Physician)
- Medicare participating
At a glance
- Medical school
- Louisiana State University School of Medicine in New Orleans (2003)
- Years since graduation
- 23
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 609
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2003Medical school: Louisiana State University School of Medicine in New Orleans
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
LA license 024394
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Ochsner Lafayette General Medical Center Lafayette, LA
- Our Lady of Lourdes Regional Medical Center, Inc Lafayette, LA
- Opelousas General Health System Opelousas, LA
- Ochsner St Martin Hospital Breaux Bridge, LA
- Ochsner American Legion Hospital Jennings, LA
Medical groups
- Acadiana Renal Physicians Amc (17 clinicians)
- Louisiana Kidney Update LLC (2 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 609
- Services billed
- 3,306
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 805 | 271 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 421 | 63 |
| Creatinine level to test for kidney function or muscle injury | 289 | 110 |
| Automated urinalysis test | 278 | 107 |
| Established patient office or other outpatient visit, 30-39 minutes | 275 | 101 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 232 | 199 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 207 | 118 |
| Hemodialysis procedure with physician evaluation | 102 | 63 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 74 | 37 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 65 | 48 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Farxiga (dapagliflozin propanediol) Other prescribers in Lafayette, LA | 470 |
| Lokelma (sodium zirconium cyclosilicate) Other prescribers in Lafayette, LA | 307 |
| Ramipril Other prescribers in Lafayette, LA | 275 |
| Amlodipine Besylate Other prescribers in Lafayette, LA | 266 |
| Sevelamer Carbonate Other prescribers in Lafayette, LA | 256 |
| Clonidine Other prescribers in Lafayette, LA | 180 |
| Auryxia (ferric citrate) | 111 |
| Velphoro (sucroferric oxyhydroxide) | 103 |
| Furosemide Other prescribers in Lafayette, LA | 75 |
| Carvedilol Other prescribers in Lafayette, LA | 75 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 15 payments worth $9,965 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $9,787 |
|---|---|
| Coloplast Corp | $178 |
| Compensation for services other than consulting (speaking, faculty) | $7,600 |
|---|---|
| Travel and Lodging | $1,779 |
| Food and Beverage | $586 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Sep 16, 2025 | Compensation for services other than consulting (speaking, faculty) LOKELMA · Cardiovascular and Metabolism Company’s descriptionSpeaker Fee | $3,200 |
| AstraZeneca Pharmaceuticals LP Sep 16, 2025 | Compensation for services other than consulting (speaking, faculty) LOKELMA · Cardiovascular and Metabolism Company’s descriptionSpeaker Fee | $2,800 |
| AstraZeneca Pharmaceuticals LP May 13, 2025 | Compensation for services other than consulting (speaking, faculty) LOKELMA · Cardiovascular and Metabolism Company’s descriptionSpeaker Fee | $1,600 |
| AstraZeneca Pharmaceuticals LP Sep 11, 2025 | Travel and Lodging LOKELMA · Cardiovascular and Metabolism · travel to Tullahoma, TN · in-kind Company’s descriptionSpeaker Expenses | $835 |
| AstraZeneca Pharmaceuticals LP Sep 11, 2025 | Travel and Lodging LOKELMA · Cardiovascular and Metabolism · travel to Tullahoma, TN · in-kind Company’s descriptionSpeaker Expenses | $709 |
| AstraZeneca Pharmaceuticals LP Sep 11, 2025 | Travel and Lodging LOKELMA · Cardiovascular and Metabolism · travel to Tullahoma, TN · in-kind Company’s descriptionSpeaker Expenses | $235 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.